Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Common Equity: 2022

Historic Common Equity for ADC Therapeutics (ADCT) over the last 1 years, with Dec 2022 value amounting to $79.5 million.

  • ADC Therapeutics' Common Equity was N/A to $79.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was $79.5 million, marking a year-over-year change of. This contributed to the annual value of $79.5 million for FY2022, which is N/A change from last year.
  • Per ADC Therapeutics' latest filing, its Common Equity stood at $79.5 million for FY2022.
  • ADC Therapeutics' Common Equity's 5-year high stood at $79.5 million during FY2022, with a 5-year trough of $79.5 million in FY2022.
  • In the last 1 years, ADC Therapeutics' Common Equity had a median value of $79.5 million in 2022 and averaged $79.5 million.